Sat, Jan 31, 2015, 7:55 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • johngunn51 johngunn51 Feb 22, 2013 11:05 AM Flag

    Single Agent First Line Therapy is Goal

    According to my people at Genentech, the drug has no systemic toxicity itself and is more effective than either Herceptin or Taxane. The box warnings are standard and reflect the incoming conditions of the study group- all of whom were people who were very ill and heavily exposed to chemo. The beauty of TDM1 is it goes only to the tumors. There is no hair loss, no nausea. Ongoing studies as first line single agent therapy will be completed in several months. Genentech expects the drug label to be officially expanded by the end of the year. Meanwhile, it will be used off label. What is 5% of $9Billion?

7.63+1.4300(+23.06%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.